Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate...

Descripción completa

Detalles Bibliográficos
Autores principales: Laetsch, Theodore W., Maude, Shannon L., Rives, Susana, Hiramatsu, Hidefumi, Bittencourt, Henrique, Bader, Peter, Baruchel, André, Boyer, Michael, De Moerloose, Barbara, Qayed, Muna, Buechner, Jochen, Pulsipher, Michael A., Myers, Gary Douglas, Stefanski, Heather E., Martin, Paul L., Nemecek, Eneida, Peters, Christina, Yanik, Gregory, Khaw, Seong Lin, Davis, Kara L., Krueger, Joerg, Balduzzi, Adriana, Boissel, Nicolas, Tiwari, Ranjan, O'Donovan, Darragh, Grupp, Stephan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
CLINICAL TRIAL UPDATES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022844/
https://www.ncbi.nlm.nih.gov/pubmed/36399695
http://dx.doi.org/10.1200/JCO.22.00642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022844/
https://www.ncbi.nlm.nih.gov/pubmed/36399695
http://dx.doi.org/10.1200/JCO.22.00642

Ejemplares similares